Bristol-Myers Squibb has issued a `Dear Health Care Provider' letter advising of a change in the pregnancy category for Sustiva [efavirenz]

By  

Reactions Weekly, Vol. 1, Iss. 1056, 2005-01 ,pp. : 3-3

Adis International

Access to resources Recommend Favorite

Bristol-Myers Squibb has announced that it will no longer make or sell the antidepressant Serzone

By  

Reactions Weekly, Vol. 1, Iss. 1007, 2004-01 ,pp. : 3-3

Adis International

Access to resources Recommend Favorite

The protease inhibitor atazanavir [Reyataz; Bristol-Myers Squibb] has been approved in the EU

By  

Inpharma, Vol. 1, Iss. 1430, 2004-01 ,pp. : 22-22

Adis International

Access to resources Recommend Favorite

Dasatinib Treatment for Imatinib Resistant or Intolerant Patients with Chronic Myeloid Leukaemia

By Li J   Xu G   Yu S   He L   Guo L  

The Journal of International Medical Research, Vol. 39, Iss. 2, 2011-03 ,pp. : 337-347

Field House Publishing

Access to resources Recommend Favorite

Dasatinib: A Review of its Use in the Treatment of Chronic Myeloid Leukaemia and Philadelphia Chromosome-Positive Acute Lymphoblastic Leukaemia

By McCormack Paul L.   Keam Susan J.  

Drugs, Vol. 71, Iss. 13, 2011-09 ,pp. : 1771-1795

Adis International

Access to resources Recommend Favorite